Page results
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease. It outlines the importance of having your heart checked as part of your care.
-
The Royal National ENT Voice Centre is a national and international multidisciplinary centre for voice disorders. The voice clinic at the RNENT is one of the oldest in the UK.
File results
-
FOI/2024/0368 - Treatment in renal cell carcinoma
-
FOI/2023/0418 - GIDS service patient referrals and treatment
-
FOI/2022/0655 - GIDS patients who have been prescribed GnRH analogues
-
FOI/2024/0480 - Freedom of Information (FOI) requests 2020/21-2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024